MetaADEDB 2.0 @ LMMD
pitavastatin
(RHGYHLPFVJEAOC-FFNUKLMVSA-L)
Structure
SMILES
O[C@H](C[C@@H](/C=C/c1c(nc2c(c1c1ccc(cc1)F)cccc2)C1CC1)O)CC(=O)[O-].O[C@H](C[C@@H](/C=C/c1c(nc2c(c1c1ccc(cc1)F)cccc2)C1CC1)O)CC(=O)[O-].[Ca+2]
Molecular Formula:
C50H46CaF2N2O8
Molecular Weight:
880.984
Log P:
6.3668
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
186.96
CAS Number(s):
147511-69-1; 147526-32-7
Synonym(s)
1.
pitavastatin
2.
(E,3R,5S)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
3.
NK 104
4.
NK-104
5.
P 872441
6.
P-872441
7.
itavastatin
8.
itavastatin calcium
9.
nisvastatin
10.
pitavastatin calcium
11.
pitavastatin lactone
External Link(s)
MeSHC108475
PubChem Compound11251522
5282451
ChEBI71258
94569
CHEMBLCHEMBL1237061
KEGGdr:D01862
Therapeutic Target DatabaseD0H9WN
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MyalgiaFAERS: 82US FAERS
2Blood creatine phosphokinase increasedFAERS: 26US FAERS
3HeadacheFAERS: 21US FAERS
4ArthralgiaFAERS: 20US FAERS
5DizzinessFAERS: 17US FAERS
6Wrong technique in product usage processFAERS: 17US FAERS
7Back PainFAERS: 15US FAERS
8FatigueFAERS: 15US FAERS
9RhabdomyolysisFAERS: 14US FAERS
10AstheniaFAERS: 12US FAERS
11Myocardial InfarctionFAERS: 12US FAERS
12MalaiseFAERS: 11US FAERS
13NauseaFAERS: 11US FAERS
14PainFAERS: 11US FAERS
15Alanine Aminotransferase IncreasedFAERS: 9US FAERS
16Aspartate Aminotransferase IncreasedFAERS: 9US FAERS
17ConstipationFAERS: 9US FAERS
18Wrong technique in drug usage processFAERS: 9US FAERS
19No adverse eventFAERS: 8US FAERS
20Chest PainFAERS: 7US FAERS
21Feeling abnormalFAERS: 7US FAERS
22Musculoskeletal PainFAERS: 7US FAERS
23AbasiaFAERS: 6US FAERS
24Abdominal PainFAERS: 6US FAERS
25Abdominal discomfortFAERS: 6US FAERS
26AmnesiaFAERS: 6US FAERS
27Memory impairmentFAERS: 6US FAERS
28PruritusFAERS: 6US FAERS
29VomitingFAERS: 6US FAERS
30Weight decreasedFAERS: 6US FAERS
31AlopeciaFAERS: 5US FAERS
32Blood glucose increasedFAERS: 5US FAERS
33Drug ineffectiveFAERS: 5US FAERS
34DysgeusiaFAERS: 5US FAERS
35Inappropriate schedule of drug administrationFAERS: 5US FAERS
36Joint swellingFAERS: 5US FAERS
37NasopharyngitisFAERS: 5US FAERS
38TremorFAERS: 5US FAERS
39UrticariaFAERS: 5US FAERS
40Low density lipoprotein increasedFAERS: 4US FAERS
41Musculoskeletal stiffnessFAERS: 4US FAERS
42MyopathyFAERS: 4US FAERS
43PalpitationsFAERS: 4US FAERS
44SomnolenceFAERS: 4US FAERS
45Activities of daily living impairedFAERS: 3US FAERS
46Blood alkaline phosphatase increasedFAERS: 3US FAERS
47Blood triglycerides increasedFAERS: 3US FAERS
48ChillsFAERS: 3US FAERS
49ChromaturiaFAERS: 3US FAERS
50DisorientationFAERS: 3US FAERS
51Dry skinFAERS: 3US FAERS
52DyspepsiaFAERS: 3US FAERS
53Guillain-Barre SyndromeFAERS: 3US FAERS
54PancreatitisFAERS: 3US FAERS
55AnxietyFAERS: 2US FAERS
56AscitesFAERS: 2US FAERS
57Blood cholesterol increasedFAERS: 2US FAERS
58Cerebral InfarctionFAERS: 2US FAERS
59Cold sweatFAERS: 2US FAERS
60Diabetes MellitusFAERS: 2US FAERS
61DysarthriaFAERS: 2US FAERS
62Epigastric discomfortFAERS: 2US FAERS
63Erectile dysfunctionFAERS: 2US FAERS
64ErythemaFAERS: 2US FAERS
65Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
66HungerFAERS: 2US FAERS
67HypersensitivityFAERS: 2US FAERS
68Incorrect dose administeredFAERS: 2US FAERS
69InfectionFAERS: 2US FAERS
70Lip swellingFAERS: 2US FAERS
71LymphadenopathyFAERS: 2US FAERS
72LymphomaFAERS: 2US FAERS
73Middle insomniaFAERS: 2US FAERS
74Miller Fisher SyndromeFAERS: 2US FAERS
75Myoglobin blood increasedFAERS: 2US FAERS
76MyositisFAERS: 2US FAERS
77Neck PainFAERS: 2US FAERS
78NeuralgiaFAERS: 2US FAERS
79PneumoniaFAERS: 2US FAERS
80Retinal DetachmentFAERS: 2US FAERS
81RhinitisFAERS: 2US FAERS
82ThrombosisFAERS: 2US FAERS
83Transaminases increasedFAERS: 2US FAERS
84Adenosquamous cell lung cancerFAERS: 1US FAERS
85Alanine aminotransferase abnormalFAERS: 1US FAERS
86Amylase abnormalFAERS: 1US FAERS
87Anaphylactic shockFAERS: 1US FAERS
88AngioedemaFAERS: 1US FAERS
89AphasiaFAERS: 1US FAERS
90AphoniaFAERS: 1US FAERS
91ArthritisFAERS: 1US FAERS
92Aspartate aminotransferase abnormalFAERS: 1US FAERS
93AsterixisFAERS: 1US FAERS
94Atrial FibrillationFAERS: 1US FAERS
95Blood bilirubin abnormalFAERS: 1US FAERS
96Blood lactate dehydrogenase increasedFAERS: 1US FAERS
97Blood pressure fluctuationFAERS: 1US FAERS
98Blood urine presentFAERS: 1US FAERS
99Burning sensationFAERS: 1US FAERS
100Chest discomfortFAERS: 1US FAERS
101CholecystitisFAERS: 1US FAERS
102CholestasisFAERS: 1US FAERS
103ClumsinessFAERS: 1US FAERS
104Consciousness fluctuatingFAERS: 1US FAERS
105Coronary Artery DiseaseFAERS: 1US FAERS
106CryingFAERS: 1US FAERS
107DeafnessFAERS: 1US FAERS
108DehydrationFAERS: 1US FAERS
109Depressed Level of ConsciousnessFAERS: 1US FAERS
110Device FailureFAERS: 1US FAERS
111DiplopiaFAERS: 1US FAERS
112DiscomfortFAERS: 1US FAERS
113Drug administered to patient of inappropriate ageFAERS: 1US FAERS
114Drug effect incompleteFAERS: 1US FAERS
115DysuriaFAERS: 1US FAERS
116Ear discomfortFAERS: 1US FAERS
117Electrocardiogram abnormalFAERS: 1US FAERS
118EnteritisFAERS: 1US FAERS
119EnterocolitisFAERS: 1US FAERS
120Eosinophilic FasciitisFAERS: 1US FAERS
121EpistaxisFAERS: 1US FAERS
122Erythema MultiformeFAERS: 1US FAERS
123Feeling ColdFAERS: 1US FAERS
124Flank PainFAERS: 1US FAERS
125FlatulenceFAERS: 1US FAERS
126FlushingFAERS: 1US FAERS
127Gait inabilityFAERS: 1US FAERS
128GastroenteritisFAERS: 1US FAERS
129General physical health deteriorationFAERS: 1US FAERS
130Genital erythemaFAERS: 1US FAERS
131GlaucomaFAERS: 1US FAERS
132Heat CrampsFAERS: 1US FAERS
133HyperphagiaFAERS: 1US FAERS
134HypersomniaFAERS: 1US FAERS
135IleusFAERS: 1US FAERS
136Impaired driving abilityFAERS: 1US FAERS
137Impaired gastric emptyingFAERS: 1US FAERS
138Impaired work abilityFAERS: 1US FAERS
139Inability to afford medicationFAERS: 1US FAERS
140IndurationFAERS: 1US FAERS
141InflammationFAERS: 1US FAERS
142Initial insomniaFAERS: 1US FAERS
143Intentional product misuseFAERS: 1US FAERS
144Irritable Bowel SyndromeFAERS: 1US FAERS
145Joint stiffnessFAERS: 1US FAERS
146Large intestine perforationFAERS: 1US FAERS
147LethargyFAERS: 1US FAERS
148Limb injuryFAERS: 1US FAERS
149Lipase abnormalFAERS: 1US FAERS
150Mental impairmentFAERS: 1US FAERS
151MonoplegiaFAERS: 1US FAERS
152Muscle tightnessFAERS: 1US FAERS
153Musculoskeletal discomfortFAERS: 1US FAERS
154OphthalmoplegiaFAERS: 1US FAERS
155Oropharyngeal painFAERS: 1US FAERS
156PancytopeniaFAERS: 1US FAERS
157ParesisFAERS: 1US FAERS
158Partner stressFAERS: 1US FAERS
159Peripheral swellingFAERS: 1US FAERS
160Personality ChangeFAERS: 1US FAERS
161PharyngitisFAERS: 1US FAERS
162Physical examination abnormalFAERS: 1US FAERS
163PolydipsiaFAERS: 1US FAERS
164PolymyositisFAERS: 1US FAERS
165PolyuriaFAERS: 1US FAERS
166Prescribed overdoseFAERS: 1US FAERS
167Pulmonary congestionFAERS: 1US FAERS
168PyelonephritisFAERS: 1US FAERS
169Rotator cuff syndromeFAERS: 1US FAERS
170Saliva alteredFAERS: 1US FAERS
171Sexual DysfunctionFAERS: 1US FAERS
172SluggishnessFAERS: 1US FAERS
173Stevens-Johnson SyndromeFAERS: 1US FAERS
174Sudden deathFAERS: 1US FAERS
175Suicide attemptFAERS: 1US FAERS
176SwellingFAERS: 1US FAERS
177SyncopeFAERS: 1US FAERS
178Synovial CystFAERS: 1US FAERS
179TalipesFAERS: 1US FAERS
180Throat irritationFAERS: 1US FAERS
181ToothacheFAERS: 1US FAERS
182Toxic Epidermal NecrolysisFAERS: 1US FAERS
183Toxicity to various agentsFAERS: 1US FAERS
184Unevaluable eventFAERS: 1US FAERS
185Urinary RetentionFAERS: 1US FAERS
186Urinary tract infectionFAERS: 1US FAERS
187Vaginal DischargeFAERS: 1US FAERS
188VasculitisFAERS: 1US FAERS
189VertigoFAERS: 1US FAERS
190Visual ImpairmentFAERS: 1US FAERS
191White blood cell count decreasedFAERS: 1US FAERS
192colonoscopyFAERS: 1US FAERS
193jaundiceFAERS: 1US FAERS
194muscle injuryFAERS: 1US FAERS
195nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.